Treace Medical Concepts
TMCI
76 hedge funds and large institutions have $387M invested in Treace Medical Concepts in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 13 closing their positions.
2,385% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $438K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 30
8% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 13
1% less funds holding
Funds holding: 77 → 76 (-1)
10% less capital invested
Capital invested by funds: $431M → $387M (-$44.5M)
17.63% less ownership
Funds ownership: 54.96% → 37.33% (-18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$13.7M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$9.59M |
| 3 |
Millennium Management
New York
|
+$8.04M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$6.39M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$3.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$211M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.39M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$3.69M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.56M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.07M |
TMCI Hedge Fund Activity: Q1 2022 in Review
76 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2022, worth a combined $387M — down 10% from $431M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of TMCI and 12 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 30 added.
The largest buyer was AllianceBernstein, adding an estimated $13.7M. The largest seller was CIBC Private Wealth Group, cutting an estimated $211M.
- 76 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2022, down from 77 in Q4 2021.
- Funds reported $387M of Treace Medical Concepts stock for Q1 2022, down 10% quarter-over-quarter.
- 12 funds opened new Treace Medical Concepts positions in Q1 2022 and 13 closed out, a net change of -1 holder.
- The largest Treace Medical Concepts buyer in Q1 2022 was AllianceBernstein, an estimated $13.7M added.
- The largest Treace Medical Concepts seller in Q1 2022 was CIBC Private Wealth Group, an estimated $211M sold.
Based on aggregated 13F filings for Q1 2022.